Leading inhalation APIs expert Inke to triple production capacity

To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs BARCELONA, Spain, April 20, 2022 /PRNewswire/ -- Inke, a leading global manufacturer of...